Most children diagnosed with lymphoma are first brought to a doctor because a parent noticed a swollen lump, usually in the neck, armpit, or groin, that didn’t go away on its own. The path from that first concern to a confirmed diagnosis typically takes several weeks and involves a series of steps: physical exams, blood tests, imaging scans, and ultimately a biopsy of the affected tissue. Understanding what each step looks for, and why it’s needed, can make the process feel less overwhelming.
The Symptoms That Usually Come First
Swollen lymph nodes are the most common reason parents seek medical attention. Children get swollen glands all the time from colds and infections, so most cases turn out to be nothing serious. The difference with lymphoma is that the swelling tends to persist for weeks, often without pain, and doesn’t resolve after an infection clears up. Nodes that feel firm or rubbery, are larger than about one centimeter, or seem fixed in place rather than freely movable raise more concern than soft, tender, mobile ones.
Beyond the lump itself, many parents report noticing what doctors call “B symptoms”: fevers that come and go without an obvious cause, drenching night sweats (not just mild warmth, but soaking through pajamas and sheets), and unexplained weight loss. Persistent fatigue, itchy skin, a cough that won’t quit, or pain in the chest, abdomen, or bones can also be part of the picture. None of these symptoms on their own means lymphoma, but a combination that lingers for more than two to three weeks is worth investigating.
Why It’s Often Mistaken for Something Else
One of the most frustrating parts of the diagnostic journey for many families is the waiting period when doctors reasonably assume a more common cause. Swollen lymph nodes in children are far more likely to result from routine infections, mononucleosis, or other reactive conditions than from cancer. Some of these benign conditions can closely mimic lymphoma, with enlarged nodes, fever, and fatigue that look nearly identical on the surface. Infectious mononucleosis is a particularly common look-alike.
This overlap means doctors often take a “watch and wait” approach initially, prescribing antibiotics or simply monitoring the swelling for a few weeks. The median time from first symptoms to a confirmed lymphoma diagnosis in children has been measured at roughly three to five weeks for many cases, though it can stretch longer depending on the child’s age and how the symptoms present. If nodes don’t shrink after a reasonable observation period, or if new symptoms develop, the workup moves to the next level.
Blood Tests and Physical Exam
A complete blood count is one of the first tests ordered. It doesn’t diagnose lymphoma directly, but it can reveal red flags. Low red blood cell counts (anemia), low platelet counts, or abnormal white blood cell numbers can suggest that something is affecting the bone marrow or causing unusual cell turnover. Very high white blood cell counts or very low counts of infection-fighting cells are taken especially seriously.
Doctors also commonly check a marker called LDH, which reflects how quickly cells are breaking down and regenerating. Elevated LDH is frequently seen in aggressive lymphomas. Again, none of these blood results prove lymphoma on their own. They’re pieces of a puzzle that help the medical team decide whether imaging and biopsy are warranted. During the physical exam, the doctor will feel for enlarged lymph nodes in multiple areas and check whether the spleen or liver feels larger than normal.
Imaging Scans to See Inside the Body
If bloodwork and physical findings raise suspicion, imaging is the next step. The goal is to see where enlarged nodes or masses are located and how widespread they might be. For children, the preferred approach in many centers is a combined PET/MRI scan. This pairing gives doctors two kinds of information at once: the MRI shows detailed structural images of tissues, while the PET component highlights areas of unusually high metabolic activity, which is a hallmark of cancer cells consuming more glucose than surrounding tissue.
PET/MRI is favored over PET/CT for children because it delivers roughly 80% less radiation, an important consideration for young patients who have decades of life ahead. Radiologists look at the size of any suspicious areas and measure their metabolic activity. Lesions with activity levels clearly above the body’s background level are flagged for further investigation. These scans also become the baseline for tracking how well treatment works later on, since tumors often show reduced metabolic activity before they physically shrink.
The Biopsy: The Step That Confirms the Diagnosis
No amount of blood tests or imaging can definitively diagnose lymphoma. That requires a biopsy, where tissue from a suspicious lymph node is removed and examined under a microscope. This is the step that gives families a definitive answer.
The gold standard is an excisional biopsy, where an entire lymph node (or a large portion of one) is surgically removed. This approach provides the most tissue for pathologists to analyze and successfully reaches a complete diagnosis in 95% to 98% of cases. A core needle biopsy, which uses a hollow needle to extract a cylinder of tissue, is a less invasive alternative that yields a complete diagnosis in roughly 84% to 92% of cases. It may be used when the suspicious node is in a location that makes surgery more complicated.
Fine needle aspiration, where a thin needle draws out individual cells, is not recommended for diagnosing lymphoma. It doesn’t capture enough of the tissue’s architecture for pathologists to determine the specific type of lymphoma, which is critical for choosing the right treatment. If your child’s team suggests a biopsy, it’s worth asking which type they plan to use and why.
Bone Marrow Testing for Staging
Once lymphoma is confirmed through biopsy, doctors need to determine how far it has spread. This process is called staging, and it directly influences treatment decisions. For both Hodgkin and non-Hodgkin lymphoma, a bone marrow aspiration and biopsy is a standard part of the staging workup. A small sample of marrow is drawn from the back of the hip bone, typically under sedation or general anesthesia in children.
The purpose is to check whether lymphoma cells have infiltrated the bone marrow. If they have, it changes the stage of the disease and may affect the intensity of treatment needed. For non-Hodgkin lymphoma in children, staging follows the St. Jude/Murphy system, which is specifically designed for pediatric patients and differs from the adult staging systems. Hodgkin lymphoma uses a separate but related staging framework.
What the Stages Mean
Staging ranges from Stage I (disease limited to a single group of lymph nodes or a single area outside the lymph system) through Stage IV (widespread involvement, potentially including the bone marrow or multiple organs). Higher stages don’t automatically mean a worse outcome in children. Pediatric lymphoma responds well to treatment across all stages, though more advanced disease generally requires more intensive therapy.
In high-income countries, five-year survival rates for pediatric Hodgkin lymphoma have reached approximately 99%. For non-Hodgkin lymphoma in children, five-year survival ranges from 85% to 95% depending on the subtype. These numbers reflect decades of progress in treatment protocols. Relapse remains the primary cause of treatment failure, but the vast majority of children diagnosed today are cured.
Questions Worth Asking During Diagnosis
The diagnostic phase moves quickly once it gets going, and it’s easy to feel swept along. St. Jude Children’s Research Hospital recommends parents ask their child’s team several key questions early on: What exact type of lymphoma does my child have? Can you walk me through the pathology report and imaging results in plain language? What additional tests or procedures are still needed, and how should we prepare our child for them? And, importantly: should we seek a second opinion, and can you help arrange one?
A second opinion on the pathology is especially valuable. Lymphoma has many subtypes, and the specific subtype determines the treatment plan. Having another expert pathologist review the biopsy tissue is a standard, accepted practice that no good oncologist will discourage. Many pediatric cancer centers do this routinely as part of their intake process.